|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin J, Chuang CC and Zuo L: Potential
roles of microRNAs and ROS in colorectal cancer: Diagnostic
biomarkers and therapeutic targets. Oncotarget. 8:17328–17346.
2017.PubMed/NCBI
|
|
3
|
Fang Y, Liang X, Jiang W, Li J, Xu J and
Cai X: Cyclin B1 suppresses colorectal cancer invasion and
metastasis by regulating e-cadherin. PLoS One. 10:e01268752015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schreuders EH, Ruco A, Rabeneck L, Schoen
RE, Sung JJ, Young GP and Kuipers EJ: Colorectal cancer screening:
A global overview of existing programmes. Gut. 64:1637–1649. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeyakumar A, Dissabandara L and Gopalan V:
A critical overview on the biological and molecular features of red
and processed meat in colorectal carcinogenesis. J Gastroenterol.
52:407–418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakamoto N, Feng Y, Stolfi C, Kurosu Y,
Green M, Lin J, Green ME, Sentani K, Yasui W, McMahon M, et al:
BRAFV600E cooperates with CDX2 inactivation to promote
serrated colorectal tumorigenesis. Elife. 6:e203312017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Raskov H, Pommergaard HC, Burcharth J and
Rosenberg J: Colorectal carcinogenesis-update and perspectives.
World J Gastroenterol. 20:18151–18164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lech G, Słotwiński R, Słodkowski M and
Krasnodębski IW: Colorectal cancer tumour markers and biomarkers:
Recent therapeutic advances. World J Gastroenterol. 22:1745–1755.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang L, Wang X, Wen C, Yang X, Song M,
Chen J, Wang C, Zhang B, Wang L, Iwamoto A, et al: Hsa-miR-19a is
associated with lymph metastasis and mediates the TNF-α induced
epithelial-to-mesenchymal transition in colorectal cancer. Sci Rep.
5:133502015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kurebayashi H, Goi T, Shimada M, Tagai N,
Naruse T, Nakazawa T, Kimura Y, Hirono Y and Yamaguchi A:
Prokineticin 2 (PROK2) is an important factor for angiogenesis in
colorectal cancer. Oncotarget. 6:26242–26251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ingebrigtsen VA, Boye K, Nesland JM,
Nesbakken A, Flatmark K and Fodstad Ø: B7-H3 expression in
colorectal cancer: Associations with clinicopathological parameters
and patient outcome. BMC Cancer. 14:6022014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamaguchi K, Yamaguchi R, Takahashi N,
Ikenoue T, Fujii T, Shinozaki M, Tsurita G, Hata K, Niida A, Imoto
S, et al: Overexpression of cohesion establishment factor DSCC1
through E2F in colorectal cancer. PLoS One. 9:e857502014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thomas J, Ohtsuka M, Pichler M and Ling H:
MicroRNAs: Clinical relevance in colorectal cancer. Int J Mol Sci.
16:28063–28076. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lam SY, Yu J, Wong SH, Peppelenbosch MP
and Fuhler GM: The gastrointestinal microbiota and its role in
oncogenesis. Best Pract Res Clin Gastroenterol. 31:607–618. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang K and Chen Y: Analysis of a novel
protein in human colorectal adenocarcinoma. Mol Med Rep. 8:529–534.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wen X, Zhu J, Dong L and Chen Y: The role
of c2orf68 and PI3K/Akt/mTOR pathway in human colorectal cancer.
Med Oncol. 31:922014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Y, Jiang T, Shi L and He K: hcrcn81
promotes cell proliferation through Wnt signaling pathway in
colorectal cancer. Med Oncol. 33:32016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha
TK, Byun DS, Chae KS, Lee BH, Chun HS, et al: NF-kappaB activates
transcription of the RNA-binding factor HuR, via PI3K-AKT
signaling, to promote gastric tumorigenesis. Gastroenterology.
135:2030–2042.e1-e3. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He K, Shi L, Jiang T, Li Q, Chen Y and
Meng C: Association between SET expression and glioblastoma cell
apoptosis and proliferation. Oncol Lett. 12:2435–2444. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Woodhoo A, Iruarrizaga-Lejarreta M, Beraza
N, García-Rodríguez JL, Embade N, Fernández-Ramos D, Martínez-López
N, Gutiérrez-De Juan V, Arteta B, Caballeria J, et al: Human
antigen R contributes to hepatic stellate cell activation and liver
fibrosis. Hepatology. 56:1870–1882. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang LF, Lou JT, Lu MH, Gao C, Zhao S, Li
B, Liang S, Li Y, Li D and Liu MF: Suppression of miR-199a
maturation by HuR is crucial for hypoxia-induced glycolytic switch
in hepatocellular carcinoma. EMBO J. 34:2671–2685. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jakstaite A, Maziukiene A, Silkuniene G,
Kmieliute K, Gulbinas A and Dambrauskas Z: HuR mediated
post-transcriptional regulation as a new potential adjuvant
therapeutic target in chemotherapy for pancreatic cancer. World J
Gastroenterol. 21:13004–13019. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu H, Berkova Z, Mathur R, Sehgal L,
Khashab T, Tao RH, Ao X, Feng L, Sabichi AL, Blechacz B, et al: HuR
suppresses fas expression and correlates with patient outcome in
liver cancer. Mol Cancer Res. 13:809–819. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lal S, Burkhart RA, Beeharry N,
Bhattacharjee V, Londin ER, Cozzitorto JA, Romeo C, Jimbo M, Norris
ZA, Yeo CJ, et al: HuR posttranscriptionally regulates WEE1:
Implications for the DNA damage response in pancreatic cancer
cells. Cancer Res. 74:1128–1140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao L, Rao JN, Zou T, Liu L, Marasa BS,
Chen J, Turner DJ, Zhou H, Gorospe M and Wang JY: Polyamines
regulate the stability of activating transcription factor-2 mRNA
through RNA-binding Protein HuR in intestinal epithelial cells. Mol
Biol Cell. 18:4579–4590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zou T, Rao JN, Liu L, Xiao L, Yu TX, Jiang
P, Gorospe M and Wang JY: Polyamines regulate the stability of JunD
mRNA by modulating the competitive binding of its 3′ untranslated
region to HuR and AUF1. Mol Cell Biol. 30:5021–5033. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Zou T, Rao JN, Liu L, Xiao L,
Wang PY, Cui YH, Gorospe M and Wang JY: Stabilization of XIAP mRNA
through the RNA binding protein HuR regulated by cellular
polyamines. Nucleic Acids Res. 42:41432014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu L, Rao JN, Zou T, Xiao L, Wang PY,
Turner DJ, Gorospe M and Wang JY: Polyamines regulate c-Myc
translation through Chk2-dependent HuR phosphorylation. Mol Biol
Cell. 20:4885–4898. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Winkler C, Doller A, Imre G, Badawi A,
Schmid T, Schulz S, Steinmeyer N, Pfeilschifter J, Rajalingam K and
Eberhardt W: Attenuation of the ELAV1-like protein HuR sensitizes
adenocarcinoma cells to the intrinsic apoptotic pathway by
increasing the translation of caspase-2L. Cell Death Dis.
5:e13212014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aguado A, Rodríguez C, Martínez-Revelles
S, Avendaño MS, Zhenyukh O, Orriols M, Martínez-González J, Alonso
MJ, Briones AM, Dixon DA and Salaices M: HuR mediates the
synergistic effects of angiotensin II and IL-1β on vascular COX-2
expression and cell migration. Br J Pharmacol. 172:3028–3042. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Elebro J, Ben Dror L, Heby M, Nodin B,
Jirström K and Eberhard J: Prognostic effect of hENT1, dCK and HuR
expression by morphological type in periampullary adenocarcinoma,
including pancreatic cancer. Acta Oncol. 55:286–296. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li X, Zhang Q, Fan K, Li B, Li H, Qi H,
Guo J, Cao Y and Sun H: Overexpression of TRPV3 correlates with
tumor progression in non-small cell lung cancer. Int J Mol Sci.
17:4372016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sharma T, Bansal R, Haokip DT, Goel I and
Muthuswami R: SMARCAL1 negatively regulates C-Myc transcription by
altering the conformation of the promoter region. Sci Rep.
9:179102015.
|
|
35
|
Choi JE, Kang SH, Lee SJ and Bae YK:
Prognostic significance of Bcl-2 expression in non-basal
triple-negative breast cancer patients treated with
anthracycline-based chemotherapy. Tumor Biol. 35:12255–12263. 2014.
View Article : Google Scholar
|
|
36
|
Ouyang YB and Giffard RG: microRNAs affect
BCL-2 family proteins in the setting of cerebral ischemia.
Neurochem Int. 77:2–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kokontis JM, Lin HP, Jiang SS, Lin CY,
Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, et al:
Androgen suppresses the proliferation of androgen receptor-positive
castration-resistant prostate cancer cells via inhibition of Cdk2,
CyclinA, and Skp2. PLoS One. 9:e1091702014. View Article : Google Scholar : PubMed/NCBI
|
